XML 62 R48.htm IDEA: XBRL DOCUMENT v3.25.1
Employee Benefits (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Plan Award Activity
The following is a summary of the Company's stock option plan award activity during the year ended December 31, 2024 (dollars in thousands, except per share amounts):
 SharesWeighted-Average
Exercise Price		Weighted-Average
Remaining Contractual
Term In Years		Aggregate
Intrinsic Value
Outstanding at January 1, 2024
80,735 $32.28 5.36$603 
Granted6,469 39.89 
Exercised(14,111)19.09 
Forfeited— — 
Expired(257)36.57 
Outstanding at December 31, 2024
72,836 35.50 5.591,249 
Exercisable53,355 33.86 4.721,003 
Expected to vest, assuming a 0% forfeiture rate over the vesting term
72,836 $35.50 5.59$1,249 
Schedule of Weighted-average Assumptions Used in Determining Fair Value of Options Granted
The fair value of each option grant is estimated as of the grant date using the Black-Scholes option-pricing model. The fair values of options granted in 2024 and 2023 were determined using the following weighted-average assumptions as of the grant date.
Year Ended December 31,
 20242023
Annual dividend yield1.69 %1.69 %
Expected volatility28.15 %28.15 %
Risk-free interest rate4.06 %3.60 %
Expected term6.00 years6.00 years
Weighted-average grant date fair value per option granted$11.64 $11.33 
Schedule of Nonvested Restricted Stock Awards
The following is a summary of the Company's non-vested restricted stock awards for the year ended December 31, 2024:
Non-vested SharesSharesWeighted-Average
Grant-Date Fair Value
Per Share		Aggregate
Intrinsic Value
Per Share
Non-vested at January 1, 2024
15,967 $39.20 
Granted8,048 39.89 
Vested(6,872)38.19 
Non-vested at December 31, 2024
17,143 39.93 $52.65 
Expected to vest assuming a 0% forfeiture rate over the vesting term
17,143 $39.93 $52.65